Skip to main content

Table 1 Patients demographics

From: The efficacy of alpha-1A blocker (tamsulosin), antimuscarinic (solifenacin) and their combination in the management of double-J stent-related lower urinary tract symptoms: a randomized controlled study

  

Control

Tamsulosin

Solifenacin

Combined therapy

P value

Age

Mean ± SD

38 ± 7

39 ± 1

40 ± 4

39 ± 8

0.55

Sex: n (%)

Male

21 (53.8)

20 (58.8)

19 (51.4)

18 (54.4)

0.37

Female

18 (46.2)

14 (41.2)

18 (48.6)

15 (45.6)

 

Side: n (%)

Right

19 (48.7)

16 (47.1)

21 (56.8)

20 (60.6)

0.09

Left

20 (51.3)

18 (52.9)

16 (43.2)

13 (39.4)

Indications for stent fixation: n (%)

URS

27 (69.2)

22 (64.7)

21(56.8)

23 (69.7)

0.64

ESWL

8 (20.5)

9 (26.5)

11(29.7)

7 (21.2)

PNL

4 (10.3)

3 (8.8)

5 (13.5)

3 (9.1)

Stone size (mm) In URS cases

Mean ± SD

7.7 (1.9)

7.4 (1.9)

8.1 (2.2)

7.8 (1.8)

0.12

  1. URS Ureteroscopy, ESWL extracorporeal shock wave lithotripsy, PNL percutaneous nephrolithotomy